Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
4 Results
Available On-Demand
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the…
Primary Peptides Inc is a clinical-stage targeted protein degradation platform technology company…
Saghmos Therapeutics' is developing ST-62516 to prevent cardiorenal complications of contrast…
ViCardia is a clinical stage biopharma company entering Phase 2 with GP531, a potent, infusion…